New hope for rare blood disorder: Half-Matched transplants show promise

NCT ID NCT02828592

First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 25 times

Summary

This study tests a bone marrow transplant from a half-matched (haploidentical) donor for people with severe aplastic anemia, a rare condition where the bone marrow fails to make enough blood cells. The goal is to see if this approach can safely restore normal blood cell production without the need for lifelong medication. Participants receive a donor transplant followed by a drug to reduce the risk of graft-versus-host disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEVERE APLASTIC ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Blood and Marrow Transplant Group of Georgia

    RECRUITING

    Atlanta, Georgia, 30342, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Northside Hospital

    RECRUITING

    Atlanta, Georgia, 30342, United States

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.